Press Contact
For media enquiries, please reach out to: contact@aspivix.com
All
- All
- Blog
- In the media
- Press releases
IUD Insertion Is Often Painful—Can a New Tool Help? feature on Health.com
This article focuses on our new device, Carevix™, designed to reduce pain during IUD insertion. Traditional IUD insertion uses a tenaculum to grasp the cervix, which can cause pain and uterine contractions....
Aspivix and Xemperia both receive support from FIT
The Foundation for Technological Innovation is pleased to announce two new loans to Aspivix and Xemperia. Aspivix has been awarded a Tech Growth loan of CHF 500,000 for its non-traumatic device for...
First Successful IUD and Transcervical Procedures with Aspivix’s Non-Traumatic Carevix™ Performed in the US
The first successful IUD and transcervical procedures using Aspivix's non-traumatic carevix™ were performed in the U.S. This milestone underscores the potential of carevix™ to offer a gentler alternative to traditional methods. The procedures...
Innovative cervical device used for first time in US gynaecological procedures
The Swiss-based start-up Aspivix has announced the first gynaecological procedures performed with its innovative cervical device in the US. The product, a suction-based cervical device known as carevix™, aims to reduce pain and...
Bayer and ASPIVIX collaborate on women’s health device
ASPIVIX announces its partnership with Bayer (Schweiz) in Switzerland, aimed at transforming gynecological procedures. The companies are introducing carevix™, a CE-Marked cervical stabiliser designed to minimise pain and bleeding during transcervical procedures,...
Bayer (Schweiz) AG and ASPIVIX collaborate to reduce pain in Women’s Health procedures
Epalinges, Switzerland – April 15, 2024 - ASPIVIX announces its partnership with Bayer (Schweiz) AG in Switzerland, aimed at transforming gynecological procedures.Together, we are introducing Carevix™, a CE-Marked cervical stabilizer designed to...
